Inventor
LENNOX WILLIAM JOSEPH
US13 patents
⚠️ This page may combine multiple inventors who share the name “LENNOX WILLIAM JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WYETH CORP
7 patentsUS6770642B2Aug 3, 2004
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP23 citations92
US6767912B2Jul 27, 2004
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
WYETH CORP34 citations92
US7585876B2Sep 8, 2009
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP8 citations84
US6903112B2Jun 7, 2005
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
WYETH CORP14 citations84
US7297705B2Nov 20, 2007
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP8 citations73
US7022701B2Apr 4, 2006
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP10 citations73
US6800640B2Oct 5, 2004
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP9 citations73
PTC THERAPEUTICS INC
4 patentsUS7767689B2Aug 3, 2010
Carboline derivatives useful in the treatment of cancer
PTC THERAPEUTICS INC40 citations92
US7601840B2Oct 13, 2009
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC39 citations92
US8372860B2Feb 12, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US8367694B2Feb 5, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83